Clinical Trials Logo

Fecal Microbiota Transplantation clinical trials

View clinical trials related to Fecal Microbiota Transplantation.

Filter by:

NCT ID: NCT02318147 Recruiting - Acute Pancreatitis Clinical Trials

Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)

Start date: November 2016
Phase: Phase 1
Study type: Interventional

Infectious complications are responsible for most of deaths in acute pancreatitis.Intestinal barrier dysfunction and increased intestinal permeability was associated with bacterial translocation which is believed to prompted these infections.The purpose of this clinical trail is to observe the potential capability of FMT in reduce the bacterial translocation and alleviate infectious complications by the reconstruction of a gut functional state.

NCT ID: NCT01790061 Recruiting - Ulcerative Colitis Clinical Trials

Standardized Fecal Microbiota Transplantation for Ulcerative Colitis

Start date: February 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body's metabolism. Evidence from animal and human studies strongly supports the link between intestinal bacteria and inflammatory bowel diseases (IBD). Dozens of studies reported its efficacy in treatment of severe Clostridium difficile colitis. Preliminary studies using FMT for Ulcerative Colitis (UC), Crohn's diseases, irritable bowel syndrome (IBS) and constipation have also met with some success. This is an initial step into investigating the potential efficacy of standardized fecal bacteriotherapy through mid-gut (at least below duodenal papilla) for UC, the investigators propose to determine the efficiency and safety of FMT in a series of 500 patients with moderate to severe UC (Montreal classification).